Postmenopausal women [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2016-02-12 04:24 (3779 d 02:08 ago) – Posting: # 15979
Views: 39,102

Dear Dan,

❝ I tested oral contraceptives in men and it was accepted by FDA and EMA.


the assay was regulatory submission or an exploratory test?
Without any doubt of your information, but is there a public assessment document from FDA and EMA?

In ANVISA guidelines is described: If the drug is indicated for patients with specific characteristics of age and sex, the study should be fully performing in volunteers with these characteristics. I think that nobody male will talk with thin voice after a single dose of estradiol, .... but is black on white!

FDA do not the same position? See link:Product-Specific Recommendations

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
161 visitors (0 registered, 161 guests [including 20 identified bots]).
Forum time: 07:33 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5